Phio Pharmaceuticals Corp. (PHIO)

1.05 -0.03 (-2.78%) USD  |  NASDAQ  |  Jan 21, 11:12
More

Phio Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly)

Net Non-Operating Interest Income Expense (Quarterly) Chart

View Net Non-Operating Interest Income Expense (Quarterly) for PHIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Non-Operating Interest Income Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks
Start Trial
Tharimmune, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade